Search research articles
Contact Us
Filters
Showing results (61-70 of 165) with videos related to
Page
of 17
Sort By:
Veterinary Pathology
|
November 28, 2007
Over 60% of NIH extramural funding involves animal-related research
Ted Valli, Stephen W Barthold, Jerrold E Ward, et al.
Breast Cancer Research and Treatment
|
December 15, 2015
184AA3: a xenograft model of ER+ breast adenocarcinoma
William C Hines, Irene Kuhn, Kate Thi, et al.
Neuroscience Letters
|
June 17, 2023
Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
Yamah Hamsafar, Qian Chen, Alexander D Borowsky, et al.
Cancer Research
|
October 17, 2008
Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer
Jamie K Miller, David L Shattuck, Ellen Q Ingalla, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2024
Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner
Md Moazzem Hossain, Paul King, Justin Hackett, et al.
Cancer Cell
|
July 9, 2010
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors
Jianfei Qi, Koh Nakayama, Robert D Cardiff, et al.
Cancer Research
|
July 23, 2003
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
Cory Abate-Shen, Whitney A Banach-Petrosky, Xiaohui Sun, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Adaptive selection of p53 mutation metaplastic phenotypes in estrogen-independent progression of ER+ tumors: A mechanism for acquired resistance to hormonal therapy
Hyeongsun Moon, Hidetoshi Mori, Jane Chen, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 8, 2012
Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist
Tessa Buckle, Nynke S van Berg, Joeri Kuil, et al.
Science Advances
|
July 12, 2024
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors
Nick R Love, Claire Williams, Emily E Killingbeck, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 165) with videos related to
Sort By:
Page
of 17
Veterinary Pathology
|
November 28, 2007
Over 60% of NIH extramural funding involves animal-related research
Ted Valli, Stephen W Barthold, Jerrold E Ward, et al.
Breast Cancer Research and Treatment
|
December 15, 2015
184AA3: a xenograft model of ER+ breast adenocarcinoma
William C Hines, Irene Kuhn, Kate Thi, et al.
Neuroscience Letters
|
June 17, 2023
Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
Yamah Hamsafar, Qian Chen, Alexander D Borowsky, et al.
Cancer Research
|
October 17, 2008
Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer
Jamie K Miller, David L Shattuck, Ellen Q Ingalla, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 29, 2024
Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner
Md Moazzem Hossain, Paul King, Justin Hackett, et al.
Cancer Cell
|
July 9, 2010
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors
Jianfei Qi, Koh Nakayama, Robert D Cardiff, et al.
Cancer Research
|
July 23, 2003
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
Cory Abate-Shen, Whitney A Banach-Petrosky, Xiaohui Sun, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Adaptive selection of p53 mutation metaplastic phenotypes in estrogen-independent progression of ER+ tumors: A mechanism for acquired resistance to hormonal therapy
Hyeongsun Moon, Hidetoshi Mori, Jane Chen, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 8, 2012
Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist
Tessa Buckle, Nynke S van Berg, Joeri Kuil, et al.
Science Advances
|
July 12, 2024
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors
Nick R Love, Claire Williams, Emily E Killingbeck, et al.
Page
of 17